APA (7th ed.) Citation

Whi, W., Shin, J., Kim, J., Ahn, H. K., Park, Y. H., Ahn, J. S., & Lee, H. Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors. BMC.

Chicago Style (17th ed.) Citation

Whi, Wonseok, Junghoon Shin, Ji-Yeon Kim, Hee Kyung Ahn, Yeon Hee Park, Jin Seok Ahn, and Hyunjong Lee. Prognostic Value of FDG PET/CT in De Novo Stage IV Breast Cancer Patients Treated with Cyclin-dependent Kinase 4/6 Inhibitors. BMC.

MLA (9th ed.) Citation

Whi, Wonseok, et al. Prognostic Value of FDG PET/CT in De Novo Stage IV Breast Cancer Patients Treated with Cyclin-dependent Kinase 4/6 Inhibitors. BMC.